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Abstract The aim of this research was to evaluate the
process of bone regeneration in rabbits, using chitosan and
beta-tricalcium phosphate (b-TCP) independently and in
combination. A total of 12 New Zealand rabbits of both
sexes, with average weight of 3.0 ± 0.57 kg were used.
Animals were randomly divided into two experimental
time points, with six animals euthanized 45 days after
surgery and six euthanized 90 days after surgery. We
performed two osteotomies in each tibia. The left tibia was
used for the chitosan (QUI) and control groups, and the
right tibia was used for the b-TCP alone and in combina-
tion with chitosan (QUI?TCP) groups. Tomographic
evaluation showed no statistically significant difference
among groups; however radiopacity was higher in the
treated groups. Comparative descriptive histological eval-
uation found that treatment groups stimulated a more
pronounced tissue repair reaction and accelerated bone
repair. Morphometric analysis showed that treatment
groups presented statistically higher bone formation com-
pared with the control group.
1 Introduction
The use of biomaterials in orthopedic surgery is becoming
routine, allowing for greater option in cases requiring an
adjuvant for the process of bone repair. Among the list of
biomaterials, calcium phosphates are widely studied and
used in dentistry and bone surgery [1, 2]. Beta-tricalcium
phosphate (b-TCP), compared with hydroxyapatite, is more
osteoconductive with excellent biodegradation properties,
characterized by rapid absorption and replacement by new
bone matrix [3, 4]. Several studies investigating biopoly-
mers highlight the successful use of chitosan, due to its
ability to stimulate bone induction, thus favoring faster
repair [5]. This can be explained by the unique surface
property of chitosan, which stimulates macrophage recep-
tors, thus promote the release of growth factors, maxi-
mizing the osteogenic process [6–8]. Several combinations
of biomaterials have been studied to accelerate and maxi-
mize the regeneration of bone tissue [9]. The combination
of chitosan with b-TCP provides an alternative reparative
process for bone tissue. This composite provides, not only
a stimulus for bone induction from chitosan, but also os-
teoconductivity from the b-TCP mineral, thereby favoring
increased formation of bone matrix by osteoblasts, as
supported by previous studies [5, 10].
The objective of this study was to evaluate the bone
regeneration process, stimulated by the use of chitosan and
b-TCP, independently and combined, in rabbit tibia
defects.
2 Materials and methods
This experimental study was approved by the Ethics Com-
mittee in Research of the Veterinary Medicine Academic
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Unit, at the Federal University of Campina Grande (UAMV/
UFCG) according to the approved protocol No. 10/2012.
2.1 Animals
In this experiment 12 New Zealand adult rabbits (mean
weight 3.0 ± 0.57 kg) of both sexes were used. The ani-
mals were randomly divided into two experimental time
points, with six animals in each time group, according to
the period of euthanasia (45 or 90 days after surgery).
Animals were placed in individual cages, dewormed with
albendazole (5 % Ibazole-IBASA) by giving 20 mg/kg
orally and passed through an adjustment period of 7 days
before the start of the experiment. Animals received bal-
anced rations twice a day and were given drinking water
ad libitum throughout the experiment.
2.2 Synthesis and characterization of implants
The implants used in this study were provided by the Bioma-
terials Group, Department of Materials Engineering at the
UFCG. For preparation of the sponge implants, chitosan
(Sigma-Aldrich, Brazil, 448877, molecular weight 1.90 9
105–3.10 9 105 g/mol, deacetylation degree 75–85 %), glacial
acetic acid (Vetec, Brazil) and genipin (Sigma-Aldrich, Brazil,
6902778, molecular weight 226.23 g/mol, purity C98 %
HPLC) were used. For further processing of scaffolds, absolute
ethanol 99.5 % GL (Nuclear, Brazil), hydrated alcohol 70 %
INPM (TUPI, Brazil) and sodium hydroxide (Vetec, Brazil)
were used.
For the synthesis and characterization of b-TCP, the
method of precipitation by wetting, involving a neutraliza-
tion reaction between phosphoric acid solution (H3PO4) and
calcium hydroxide [Ca(OH)2] was used. The stoichiometric
amounts of the solutions were determined according to the
value of the atomic ratio between the calcium and phos-
phorus atoms from calcium phosphate. Powder Ca(OH)2
was added to deionized water and vigorously agitated and
heated to 80 C. To this solution, H3PO4 was slowly added
under constant agitation. After thorough mixing of the two
reactants, the temperature was raised to 100 C and agitation
was continued until viscosity was reached. The ceramic
paste obtained was dried at 110 C for 24 h and the product
was deagglomerated, passed through a 200 mesh sieve to
obtain the powder, heat-treated at 20 C per minute and held
at 1,100 C for 2 h.
2.3 Surgical procedure
After shaving, a pre-anesthesia medication of acepromazine
(Acepran 1 %, VETNIL, Brazil), 1 mg/kg was given intra-
venously (IV), and then anesthesia medication comprising
tiletamine associated with zolazepam (Zoletil 100, VIRBAC,
Brazil) was given at a dose of 15 mg/kg IV. We also per-
formed epidural anesthesia with 2 % lidocaine (anesthetic
BRAVET, BRAVET, Brazil) at a dose of 0.22 mL/kg,
associated with tramadol (Tramal-PFIZER, Brazil) at a dose
of 1 mg/kg. After antisepsis of the operative area with a
solution of chlorhexidine 0.5 % (0.5 % Riohex, RIO-
QUI´MICA, Brazil), a skin incision was made along the
medial margin of the tibial crest and dilatation of the sub-
cutaneous tissue and muscle was carried out. Longitudinal
resection of the periosteum was performed and two holes
were constructed, one in the proximal metaphysis and
another at the distal metaphysis, using a surgical drill with a
3.0-mm diameter for implant placement. Treatments were as
follows, in the left tibia; control group (C), osteotomy was
performed but not completed for any implant in the proximal
metaphysis; and chitosan group (QUI) with 85 % deacety-
lation on the distal metaphysic; and in the right tibia; the b-
TCP group (TCP) in the proximal metaphysis was introduced
at a Ca/P ratio of 1.5, and the b-TCP combined with chitosan
group (QUI?TCP) on the distal metaphysis. All implants
were autoclaved prior to use. Synthesis was performed in the
tissues. This procedure was performed in both limbs.
2.4 Postoperative
Postoperatively, animals received enrofloxacin (2.5 %
Biofloxacin, BIOVET) at a dose of 10 mg/kg intramuscu-
larly (IM), once a day for 5 days and meloxicam (0.2 %
Maxicam, FINE GOLD) at a dose of 0.2 mg/kg IM on the
first day and 0.1 mg/kg in two subsequent days. Cleaning
of the wound was performed with saline and Kuraderm
Silver (Silver Kuraderm, AVIPEC) during the first 10 days
after surgery and stitches were removed thereafter.
2.5 Computerized tomography examination
At the end of the observation period for each experimental
time point, tibias were harvested and computerized
tomography (CT) was performed, with a helical unit GE
Hi-Speed FXI and protocol with 120 kVp and auto mA, at
rotation speed of one per second. Images were acquired in
transverse sections 1 mm thick with a filter for bony parts.
After the CT scan and image processing, the amount of
attenuation in Hounsfield units (HU) of the bone was cal-
culated from the average of three regions of interest. Each
region of interest had its area previously standardized for
better uniformity of results. The software for tomographic
analysis was the E-film.
2.6 Histologic evaluation of the bone/implant interface
For microscopic evaluation, tibiae were harvested and the
fragments of bone containing the implant were removed.
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The bone fragments were chemically fixed with 10 %
buffered formalin for 10 days. Shortly after, the material
was washed with water and demineralized with a mixture
of equal parts of 5 % formic acid ? 5 % hydrochloric acid
for 14 days. Fragments were embedded in liquid paraffin
and sliced at a thickness of 5 lm transverse blocks and
mounted on slides. From each block four slides were
obtained and subjected to hematoxylin–eosin staining for
histological observation. The purpose for these observa-
tions was to evaluate the bone–implant interface degrees of
endosteal and periosteal reaction, cell proliferation, dif-
ferentiation and healing of the scar tissue on the bone
lesion. In this evaluation, we performed descriptive quali-
tative assessment and comparison between times and
groups.
2.7 Morphometric analysis of the bone/implant
interface
Osteogenesis, induced by treatment, was quantified by
morphometric analysis of slides through Image Pro Plus
Version 6.2. For these analyses, images that comprised
bone/implant interface were captured and processed.
Sequential images of each slide were analyzed to quantify,
in lm2 and mm2, new bone at the implant interface.
Average values were obtained for every group studied and
statistical analysis was performed.
2.8 Statistical evaluation
A comparison of bone regeneration, induced by treatments,
was carried out for each experimental time point and
between experimental groups. Initially we performed the
Anderson–Darling normality test for verification of the
data distribution. For normally distributed variables, the
groups were compared by one-way analysis of variance
(ANOVA), with multiple comparisons by Tukey’s test. For
variables with non-normal distribution, comparison was
performed by the nonparametric Kruskal–Wallis test with
multiple comparisons by the Nemenyi test [11]. The sig-
nificance level was 5 % and the analyses were performed
with the statistical program MINITAB Version 14.0.
3 Results
3.1 CT evaluation
CT evaluation found no statistical difference between
groups or between times. However, as highlighted in
Fig. 1, the mean HU values for the groups, TCP?QUI,
QUI and TCP, were higher in the experimental time points
studied compared with group C.
3.2 Histological descriptive evaluation
Following histological evaluation, it was observed that the
bone/implant interface for groups QUI, TCP and
QUI?TCP, showed higher cell reaction of granuloma type
than group C at day 45. A greater presence of neovascu-
larization and biomaterial–cell interaction in bone forma-
tion was also observed in the center of the granulomas in
the same groups. This reaction was more intense in groups
QUI?TCP and QUI (Fig. 2). Furthermore, a greater
amount of new bone on the bone/implant interface was
observed in the QUI and QUI?TCP groups compared with
the other groups and the reactions of the TCP group were
higher compared with group C.
Histological evaluation at day 90, revealed the bone/
implant interface of QUI and QUI?TCP groups showed a
higher cellular reaction with granuloma than the other
groups. It also showed an intense neovascularization in
those groups, which was less intense in group C. It was
observed that the biomaterials were still present and sur-
rounded by cells. All groups had advanced bone healing,
but in groups QUI and QUI?TCP, this reaction was more
pronounced than in the others (Fig. 3).
3.3 Morphometric evaluation
Morphometric evaluation of the slides revealed a statistical
difference (P = 0.036) between groups C and QUI at day
45. At day 90, there were statistical differences between
groups C and QUI (P = 0.001), C and QUI?TCP
(P = 0.0005) and C and TCP (0.003) as shown in Fig. 4.
Fig. 1 Mean and standard deviation of radiodensity in Hounsfield
units (HU) at 45 and 90 days. Osteotomized area received the
treatments; C control, QUI chitosan only, QUI?TCP chitosan in
combination with tricalcium phosphate (TCP), TCP TCP only
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4 Discussion
Tomographic evaluation of bone tissue is an applicable and
reliable research method for measuring bone density [12].
In the present study, there was no statistical difference
between groups; however groups QUI, QUI?TCP and TCP
obtained mean radiopacity higher than group C. Even in
the absence of a statistical difference, possibly owing to the
limited number of animals used in this study, there was a
trend of greater radiopacity in all groups when compared
with group C. This finding can be explained by the char-
acteristics of chitosan, which is an osteoinductive material
that stimulates the release of growth factors, differentiation
and cell aggregation in the wound, thereby promoting and
accelerating the regeneration of bone tissue [13]. When
combined with the characteristics of b-TCP, an osteocon-
ductive material that acts as a substrate, providing minerals
that favor mineralization of the extracellular matrix,
thereby stimulating osteogenesis [14], it is not surprising
the treatments in this study advance bone formation com-
pared with the control.
Descriptive histological evaluation in both the 45 and
90 day groups for QUI, QUI?TCP and TCP, identified
more intense and evident reactions compared with group C.
It could also be noted that groups QUI and QUI?TCP
showed greater reactions compared with the TCP group. In
this study, the characteristic wider and larger reactions
after treatment can be attributed to the characteristics of
chitosan, which stimulates the release of growth factors and
cell differentiation, increasing and maximizing osteogene-
sis [7–15]. Together with TCP, which promotes minerali-
zation of bone matrix, faster tissue healing occurs [16, 17].
Previous studies using different calcium phosphates have
highlighted this [9]. The combination of biopolymer with
calcium phosphate in promising [5], in enabling the
materials to synergistically promote cell differentiation and
accelerate deposition of osteoid in the bone defect, there-
fore accelerating the process of osteogenesis [18]. This was
observed in our study, whereby broad cellularity and bone
formation was evident after treatment compared with the
control.
Morphometric analysis, identified no statistically sig-
nificant difference at day 45 between groups C and QUI
and at day 90 between groups C and QUI, QUI?TCP and
TCP. In the present study, materials containing chitosan
and b-TCP stimulated bone formation to greater extent
Fig. 2 Descriptive histological evaluation at day 45. a (Control
group); red circle indicates osteotomized site filled by newly formed
immature bone. b (QUI group); red circle shows implantation of
chitosan surrounded by intense cellular reaction, dark arrows
highlight blood vessels. c (TCP group); red circle indicates
osteotomized site filled by newly formed bone tissue. d (TCP?QUI
group); red circle indicates the implant site with intense cellular
reaction around the implant and black circle highlights osteotomized
area filled by newly formed bone tissue. Obj. 94 (Color figure online)
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compared with the control group. This can be explained by
the ability of chitosan to stimulate release, at the injury site,
of interleukins 1, 6 and 8, other inflammatory factors and
macrophages, all of which accelerate the process of tissue
repair by stimulating osteogenesis [6], as observed in this
study. In a recent study, chitosan was shown to stimulate
bone formation tenfold higher compared with calcium
phosphate [19]. When used alone or combined with chito-
san, b-TCP provides calcium and phosphorous ions, which
enable osteoblasts to synthesize osteoid, thus enhancing the
bone repair process. Furthermore, calcium phosphate is
rapidly absorbed and stimulates deposition of osteoid in the
same proportion [9]. In the present experiment, we observed
that chitosan alone or combined with b-TCP favors osteo-
genesis, with enhanced bone formation in bone lesions.
5 Conclusion
We conclude that combined chitosan and b-TCP used in
this study stimulates osteogenesis to a greater extent
compared with the control group. The combination of these
biomaterials is very promising in the future repair of bone
tissue.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
Fig. 3 Descriptive histological evaluation at day 90. a (Control
group); red circle indicates osteotomized site filled by newly formed
immature bone with little cellular reaction. b (QUI group); red circle
shows implantation of chitosan surrounded by intense cellular
reaction and dark circle shows newly formed bone tissue. c (TCP
group); red circle indicates osteotomized site filled by newly formed
bone during the organization process. d (TCP?QUI group); red circle
indicates the osteotomy site filled by newly formed bone, in the
organization process, and black arrows show cellular reaction. Obj.
94 (Color figure online)
Fig. 4 Mean and standard deviation of newly formed bone tissue
(mm2) at the treatment interface. Treatments; C control, QUI chitosan
only, QUI?TCP chitosan combined with tricalcium phosphate, TCP
TCP only)
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